EX-5 5 a12-17799_1ex5.htm EX-5

Exhibit 5

 

August 8, 2012

 

 

The undersigned hereby certifies that Sarah Clements and Tony Rosenberg are authorized to execute Amendment No. 7 to Schedule 13D with respect to Idenix Pharmaceuticals, Inc., on behalf of Novartis Pharma AG.

 

 

 

/s/ Thomas Lynch

 

Name: Thomas Lynch

 

Title: Senior Legal Counsel